Cardinal Health, Inc. (CAH): Price and Financial Metrics
Cardinal Health, Inc. (CAH)
Today's Latest Price: $48.01 USD
0.07 (0.15%)
Updated Apr 1 3:55pm
Add CAH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
CAH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for CAH is 149.81 -- better than 99.86% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 11.21 for Cardinal Health Inc; that's greater than it is for 95.1% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Cardinal Health Inc is reporting a growth rate of -671.21%; that's higher than just 2.41% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cardinal Health Inc are CLMT, CSU, CL, SPWR, and XRF.
- Visit CAH's SEC page to see the company's official filings. To visit the company's web site, go to www.cardinalhealth.com.
CAH Daily Price Range
CAH 52-Week Price Range
CAH Stock Price Chart More Charts
CAH Price/Volume Stats
| Current price | $48.01 | 52-week high | $60.69 |
| Prev. close | $47.94 | 52-week low | $39.05 |
| Day low | $46.00 | Volume | 2,704,050 |
| Day high | $48.11 | Avg. volume | 3,263,880 |
| 50-day MA | $51.94 | Dividend yield | 4.01% |
| 200-day MA | $49.51 | Market Cap | 14.01B |
Cardinal Health, Inc. (CAH) Company Bio
Cardinal Health provides pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The company was founded in 1979 and is based in Dublin, Ohio.
Top Stories View All
5 Fitness Stocks for the “Modern World”
How Should Cannabis Investors Interpret Cronos Group's Earnings Report?
3 Reasons for Economic Hope in a Sea of Darkness
NYSE Suspends Trading for CannTrust (CTST) and Commences Delisting Process
Best & Worst Performing Stock Industries for March 31, 2020
View All Top Stories
Loading social stream, please wait...